Predicting tumour radiosensitivity to deliver precision radiotherapy
JM Price, A Prabhakaran, CML West - Nature Reviews Clinical …, 2023 - nature.com
Owing to advances in radiotherapy, the physical properties of radiation can be optimized to
enable individualized treatment; however, optimization is rarely based on biological …
enable individualized treatment; however, optimization is rarely based on biological …
[HTML][HTML] Nanotechnology advances in the detection and treatment of cancer: an overview
Over the last few years, progress has been made across the nanomedicine landscape, in
particular, the invention of contemporary nanostructures for cancer diagnosis and …
particular, the invention of contemporary nanostructures for cancer diagnosis and …
The association between tumor mutational burden and prognosis is dependent on treatment context
In multiple cancer types, high tumor mutational burden (TMB) is associated with longer
survival after treatment with immune checkpoint inhibitors (ICIs). The association of TMB with …
survival after treatment with immune checkpoint inhibitors (ICIs). The association of TMB with …
[HTML][HTML] Update on targeted cancer therapies, single or in combination, and their fine tuning for precision medicine
Background Until recently, patients who have the same type and stage of cancer all receive
the same treatment. It has been established, however, that individuals with the same …
the same treatment. It has been established, however, that individuals with the same …
Orbital tumours and tumour-like lesions: exploring the armamentarium of multiparametric imaging
Although the orbit is a small anatomical space, the wide range of structures present within it
are often the site of origin of various tumours and tumour-like conditions, both in adults and …
are often the site of origin of various tumours and tumour-like conditions, both in adults and …
Applicability of liquid biopsies to represent the mutational profile of tumor tissue from different cancer entities
S Liebs, T Eder, F Klauschen, M Schütte, ML Yaspo… - Oncogene, 2021 - nature.com
Genetic investigation of tumor heterogeneity and clonal evolution in solid cancers could be
assisted by the analysis of liquid biopsies. However, tumors of various entities might release …
assisted by the analysis of liquid biopsies. However, tumors of various entities might release …
[HTML][HTML] Clinical applications of PET/MRI: current status and future perspectives
F Nensa, K Beiderwellen, P Heusch… - Diagnostic and …, 2014 - ncbi.nlm.nih.gov
Fully integrated positron emission tomography (PET)/magnetic resonance imaging (MRI)
scanners have been available for a few years. Since then, the number of scanner …
scanners have been available for a few years. Since then, the number of scanner …
Prognostic and predictive factors in advanced head and neck squamous cell carcinoma
T Magnes, S Wagner, D Kiem, L Weiss… - International journal of …, 2021 - mdpi.com
Head and neck squamous cell carcinoma (HNSCC) is a heterogeneous disease arising
from the mucosa of the upper aerodigestive tract. Despite multimodality treatments …
from the mucosa of the upper aerodigestive tract. Despite multimodality treatments …
[HTML][HTML] Dynamics of cell-free tumour DNA correlate with treatment response of head and neck cancer patients receiving radiochemotherapy
FJ Hilke, F Muyas, J Admard, B Kootz, D Nann… - Radiotherapy and …, 2020 - Elsevier
Purpose Definitive radiochemotherapy (RCTX) with curative intent is one of the standard
treatment options in patients with locally advanced head and neck squamous cell carcinoma …
treatment options in patients with locally advanced head and neck squamous cell carcinoma …
Relationship between tumor mutational burden, PD-L1, patient characteristics, and response to immune checkpoint inhibitors in head and neck squamous cell …
KM Burcher, JW Lantz, E Gavrila, A Abreu, JT Burcher… - Cancers, 2021 - mdpi.com
Simple Summary Immunotherapy has prompted a dramatic change in the management of
head and neck squamous cell carcinoma (HNSCC), but the percentage of patients …
head and neck squamous cell carcinoma (HNSCC), but the percentage of patients …